Therapeutic management of posttransplant diabetes mellitus

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Diabetes mellitus continues to be a common metabolic complication after solid organ transplantation. The etiology is multifactorial and includes both modifiable and nonmodifiable factors. Immunosuppression may play a critical role in its development. Targets of treatment include oral hypoglycemics as well as insulin. More recently, several novel agents have been approved by the Food and Drug Administration for treatment of type 2 diabetes. There is limited experience with these agents in transplant recipients. Use of oral and subcutaneous therapies as well as insulin will be reviewed. As diabetes has a negative impact on patient and graft outcome, the transplant practitioner must be vigilant in screening and managing diabetes after transplantation.

Original languageEnglish (US)
Pages (from-to)116-124
Number of pages9
JournalTransplantation Reviews
Issue number2
StatePublished - Apr 2008
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation

Fingerprint Dive into the research topics of 'Therapeutic management of posttransplant diabetes mellitus'. Together they form a unique fingerprint.

Cite this